Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/esmoopen-2020-000820 http://scihub22266oqcxt.onion/10.1136/esmoopen-2020-000820 32581069!7319703!32581069     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       ESMO+Open 2020 ; 5 (Suppl 3): ä Nephropedia Template TP {{tp|p=32581069|t=2020. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer |pdf=|usr=}}{{32581069}} gab.com Text ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer JO: ESMO Open http://www.kidney.de/pget.php?&tw=1&pmid=32581069 #FOAvip The COVID-19 pandemic, characterised by a fast and global spread during the first months of 2020, has prompted the development of a structured set of recommendations for cancer care management, to maintain the highest possible standards. Within this framework, it is crucial to ensure no disruption to essential oncological services and guarantee the optimal care.This is a structured proposal for the management of lung cancer, comprising three levels of priorities, namely: tier 1 (high priority), tier 2 (medium priority) and tier 3 (low priority)-defined according to the criteria of the Cancer Care Ontario, Huntsman Cancer Institute and Magnitude of Clinical Benefit Scale.The manuscript emphasises the impact of the COVID-19 pandemic on lung cancer care and reconsiders all steps from diagnosis, staging and treatment.These recommendations should, therefore, serve as guidance for prioritising the different aspects of cancer care to mitigate the possible negative impact of the COVID-19 pandemic on the management of our patients.As the situation is rapidly evolving, practical actions are required to guarantee the best patients' treatment while protecting and respecting their rights, safety and well-being. In this environment, cancer practitioners have great responsibilities: provide timely, appropriate, compassionate and justified cancer care, while protecting themselves and their patients from being infected with COVID-19. In case of shortages, resources must be distributed fairly. Consequently, the following recommendations can be applied with significant nuances, depending on the time and location for their use, considering variable constraints imposed to the health systems. An exceptional flexibility is required from cancer caregivers. Twit Text FOAVip ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer ????ESMO Open http://www.kidney.de/pget.php?&tw=1&pmid=32581069 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32581069 #FOAvip English Wikipedia <ref>{{Cite pmid|32581069}}</ref> ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer #MMPMID32581069 Passaro A; Addeo A; Von Garnier C; Blackhall F; Planchard D; Felip E; Dziadziuszko R; de Marinis F; Reck M; Bouchaab H; Peters S ESMO Open 2020[Jun]; 5 (Suppl 3): ä PMID32581069show ga The COVID-19 pandemic, characterised by a fast and global spread during the first months of 2020, has prompted the development of a structured set of recommendations for cancer care management, to maintain the highest possible standards. Within this framework, it is crucial to ensure no disruption to essential oncological services and guarantee the optimal care.This is a structured proposal for the management of lung cancer, comprising three levels of priorities, namely: tier 1 (high priority), tier 2 (medium priority) and tier 3 (low priority)-defined according to the criteria of the Cancer Care Ontario, Huntsman Cancer Institute and Magnitude of Clinical Benefit Scale.The manuscript emphasises the impact of the COVID-19 pandemic on lung cancer care and reconsiders all steps from diagnosis, staging and treatment.These recommendations should, therefore, serve as guidance for prioritising the different aspects of cancer care to mitigate the possible negative impact of the COVID-19 pandemic on the management of our patients.As the situation is rapidly evolving, practical actions are required to guarantee the best patients' treatment while protecting and respecting their rights, safety and well-being. In this environment, cancer practitioners have great responsibilities: provide timely, appropriate, compassionate and justified cancer care, while protecting themselves and their patients from being infected with COVID-19. In case of shortages, resources must be distributed fairly. Consequently, the following recommendations can be applied with significant nuances, depending on the time and location for their use, considering variable constraints imposed to the health systems. An exceptional flexibility is required from cancer caregivers. |*Carcinoma, Non-Small-Cell Lung/pathology/therapy[MESH] |*Coronavirus Infections/epidemiology[MESH] |*Delivery of Health Care/methods[MESH] |*Lung Neoplasms/pathology/therapy[MESH] |*Pneumonia, Viral/epidemiology[MESH] |*Small Cell Lung Carcinoma/pathology/therapy[MESH] |Ambulatory Care[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Chemoradiotherapy[MESH] |Humans[MESH] |Medical Oncology[MESH] |Neoplasm Staging[MESH] |Pandemics[MESH] |Pneumonectomy[MESH] |Practice Guidelines as Topic[MESH] |Radiation Oncology[MESH] |Radiosurgery[MESH] |SARS-CoV-2[MESH] |Surgical Oncology[MESH] |Telemedicine[MESH] |Time-to-Treatment[MESH] |Tomography, X-Ray Computed[MESH]ESMO Management and treatment adapted recommendations in the COVID-19 (epmc).pdf DeepDyve Pubget Overpricing